5-Fluorouracil induced Fas upregulation associated with apoptosis in liver metastases of colorectal cancer patients

Annals of Oncology

Volumn 12, Issue 2, 2001, Pages 209-216

  Backus, H H J ^a   Dukers, D F ^a   Van Groeningen, C J ^a   Vos, W ^a   Bloemena, E ^a   Wouters, D ^a   Van Riel, J M G H ^a   Smid, K ^a   Giaccone, G ^a   Pinedo, H M ^a   Peters, G J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

5 Fluorouracil; Apoptosis; Cell cycle arrest; Colorectal cancer; Fas; Thymidylate synthase

Indexed keywords

ANTIBODY; CASPASE 3; CYTOKERATIN 18; FAS ANTIGEN; FAS LIGAND; FLUOROURACIL; FOLINIC ACID; KI 67 ANTIGEN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; THYMIDYLATE SYNTHASE; TRANSCRIPTION FACTOR E2F; TUMOR MARKER;

ADULT; AGED; APOPTOSIS; ARTICLE; BIOPSY; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CELL CYCLE; CELL KILLING; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MALE; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN DEGRADATION; T LYMPHOCYTE ACTIVATION; TUMOR CELL;

EID: 0035104753     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008331525368     Document Type: Article

References (66)

1. Biochemical modulation of fluorouracil with leucovorin: Confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer
2. Chemotherapy of gastrointestinal cancer
3. Thymidylate synthase inhibitors in cancer therapy: Direct and indirect inhibitors
4. New antimetabolites in preclinical and clinical development
5. Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil
6. Thymidylate synthase from untreated human colorectal cancer and colonic mucosa: Enzyme activity and inhibition by 5-fluoro-2′-deoxyuridine-5′-monophosphate
7. Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylate synthase inhibitors
8. Thymidylate synthase inhibition after administration of 5-fluorouracil with or without leucovorin; implications for treatment with 5-fluorouracil
9. Enhancement of the anti-tumor effects of 5-fluorouracil by folinic acid
10. Quantification of 5-fluorouracil incorporation into RNA of human and murine tumors as measured with a sensitive gas chromatography-mass spectrometry assay
11. Increased growth inhibition and DNA lesions in human colon adenocarcinoma cells treated with methotrexate and 5-fluorodeoxy-uridine followed by calmodulin inhibitors
12. Principles of Antineoplastic Drug Development and Pharmacology
13. BCL-2 modulation of apoptosis induced by anticancer drugs: Resistance to thymidylate stress is independent of classical resistance pathways
14. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
15. p53, guardian of the genome
16. p53, cell-cycle control and apoptosis: Implications for cancer
17. WAF1, a potential mediator of p53 tumor suppression
18. The retinoblastoma protein and cell-cycle control
19. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation
20. Tumor suppressor p53 is a regulator of BCL-2 and bax gene expression in vitro and in vivo
21. The proto-oncogene BCL-2 and its role in regulating apoptosis
22. Regulators of cell death
23. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
24. Expression of apo-1 (CD-95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium
25. Apoptosis by death factor
26. The Fas death factor
27. Morphological criteria for identifying apoptosis
28. Biochemical an molecular mechanisms regulating apoptosis
29. Caspase cleavage of Keratin 18 and reorganisation of intermediate filaments during epithelial cell apoptosis
30. Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE
31. 5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of BCL-2 family proteins
32. Catalyzed reporter deposition, a novel method of signal amplification. I. Application for immunoassays
33. p53 and Rb1 protein expression: Are they prognostically useful in colorectal cancer?
34. BCL-2 and p53 oncoprotein expression during colorectal tumorigenesis
35. Colorectal liver metastasis thymidylate synthase staining correlates with response to hepatic arterial floxuridine
36. p53 and thymidylate synthase expression in untreated stage II colon cancer: Associations with recurrence, survival, and site
37. Fas/Fas ligand interaction in human colorectal hepatic metastases
38. FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas
39. Prognostic significance of BCL-2, BCL-xL/S, bax and bak expressions in colorectal carcinomas
40. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (caspase-3), a cell death protease
41. Computer assisted efficiency testing of different sampling methods for selective nuclear graphic tablet morphometry
42. Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive an-negative cases of Hodgkin's disease
43. Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor Raltitrexed
44. Elevation of thymidylate synthase following 5-fluorouracil treatment is prevented by the addition of leucovorin in murine colon tumours
45. The role of thymidylate synthase as an RNA binding protein
46. Role of E2F-1 in chemo-sensitivity
47. UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner
48. Increased induction of apoptosis of human colorectal cancer cells after preoperative treatment with 5-fluorouracil
49. Effects of pertubations of pools of deoxynucleoside triphosphates on expression of ribonucleotide reductase, a G1/S transition state enzyme, in p53-mutated cells
50. DNA damage and p53 induction do not cause ZD1694-induced cell-cycle arrest in human colon carcinoma cells
51. Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system
52. Thymineless death in colon carcinoma cells is mediated via Fas signalling
53. 2+-independent T cell-mediated cytotoxicity
54. Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis
55. Thymidylate synthase expression in patients with colorectal carcinoma using a polyclonal thymidylate synthase antibody in comparison to the TS 106 monoconal antibody
56. Expression of p53, p21/waf, BCL-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas
57. WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers
58. Retinoblastoma protein in human breast carcinoma: Immunohistochemical study using a new monoclonal antibody effective on routinely processed tissues
59. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase
60. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas
61. Elevated expression of BCL-x and reduced bak in primary colorectal adenocarcinomas
62. Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of BCL-2
63. Immunohistochemical analysis of mcl-1 protein in human tissues
64. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme
65. Structural and functional analysis of poly (ADP ribose) polymerase: An immunological study
66. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis